PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Geo Genesis to assist Flourish Media on listing and fundraising

Geo Genesis Group, an advisory and investment company focussed on China and other emerging markets, has signed an agreement with Flourish Media, a Chinese based publisher of magazines, to provide a consultancy service to structure a listing and a fundraising. 

Under the terms of the agreement, Geo Genesis will assist Flourish in structuring a regulated entity, if required, to assist Flourish in raising at least USD2m in order to gain a listing on the appropriate small cap market either in the US or in the EU. 

Alternatively, Geo Genesis will help find the appropriate regulated entity to list Flourish.
 
The funds raised will partly be used for the development and implementation of a private equity publication focussed on potential international private equity institutional investors and companies seeking investment and expansion in China. The publication will be published in both Chinese and English and will include an electronic version and related data base. 

Geo Genesis will take an equity position, at Geo Genesis’ discretion, in Flourish with a view to using its international contact base to assist in the development and implementation of the publication. Involvement will relate to generating content, potential sponsors and independent directors and executives related to the publication.  
 
Geo Genesis chief executive officer Roger Bendelac says: “We continue to develop our service offering and this agreement with Flourish is in line with our strategy of utilising the board’s knowledge of emerging markets to pursue new business opportunities and identify and secure deal flow.
 
“Our knowledge and international contact base have also enabled us to participate in the development of the publication, particularly at this time of growth within the Chinese markets, and we look forward to working with Flourish to secure both the funding and vehicle necessary for their listing on the OTC-BB market and the ongoing development of their product, so that we may actively build upon our investment going forward.” 

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured